188 related articles for article (PubMed ID: 31672651)
1. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.
Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A
Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of clusterin expression in advanced-stage cervical cancer treated with curative intended radiotherapy.
Watari H; Kinoshita R; Han Y; Wang L; Hosaka M; Taguchi H; Tsuchiya K; Tanaka S; Shirato H; Sakuragi N
Int J Gynecol Cancer; 2012 Mar; 22(3):465-70. PubMed ID: 21633299
[TBL] [Abstract][Full Text] [Related]
3. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
5. Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
Wang X; Liu Y; Qin Q; Zheng T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039450
[TBL] [Abstract][Full Text] [Related]
6. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.
Hassan MK; Watari H; Han Y; Mitamura T; Hosaka M; Wang L; Tanaka S; Sakuragi N
J Exp Clin Cancer Res; 2011 Dec; 30(1):113. PubMed ID: 22185350
[TBL] [Abstract][Full Text] [Related]
7. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
8. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
9. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
[TBL] [Abstract][Full Text] [Related]
10. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
Fuzio P; Napoli A; Ciampolillo A; Lattarulo S; Pezzolla A; Nuzziello N; Liuni S; Giorgino F; Maiorano E; Perlino E
BMC Cancer; 2015 May; 15():349. PubMed ID: 25934174
[TBL] [Abstract][Full Text] [Related]
11. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
Kalioraki MA; Artemaki PI; Sklirou AD; Kontos CK; Adamopoulos PG; Papadopoulos IN; Trougakos IP; Scorilas A
Mol Carcinog; 2020 Jan; 59(1):116-125. PubMed ID: 31709619
[TBL] [Abstract][Full Text] [Related]
13. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
[TBL] [Abstract][Full Text] [Related]
14. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
16. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
17. High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype.
Huang Y; Wang G; Zhao C; Geng R; Zhang S; Wang W; Chen J; Liu H; Wang X
Dis Markers; 2019; 2019():5231269. PubMed ID: 30956730
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.
Lourda M; Trougakos IP; Gonos ES
Int J Cancer; 2007 Feb; 120(3):611-22. PubMed ID: 17096323
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clusterin immunoreactivity in breast cancer.
Krüger S; Ola V; Fischer D; Feller AC; Friedrich M
Neoplasma; 2007; 54(1):46-50. PubMed ID: 17203891
[TBL] [Abstract][Full Text] [Related]
20. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
